The biggest key players from the life science industry in Norway came together to promote Nordic collaboration.
A new clinical study indicates that medical nutrition can improve overall survival in lung cancer patients.
During Arendalsuka 2019, we arranged a breakfast meeting on the development of cancer treatments of the future, together with LMI and Kreftforeningen.
Immunitrack has been awarded a grant from Eurostars to develop their prediction tool for cancer vaccines.
The Japanese tech giant NEC Corporation has acquired OncoImmunity AS.
Oslo Cancer Cluster Incubator collaborates with partners in Sweden, Norway and Finland to help life science professionals learn from their neighbours.